Fei Ma - Search Results

Year	Number of Results
2002	4
2003	4
2004	2
2005	10
2006	5
2007	3
2008	16
2009	17
2010	15
2011	15
2012	33
2013	35
2014	47
2015	60
2016	68
2017	78
2018	74
2019	96
2020	131
2021	115
2022	145
2023	136
2024	149
2025	151
2026	49

1

Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer.

Zhang Y, Chen H, Mo H, Zhao N, Sun X, Liu B, Gao R, Xu B, Zhang Z, Liu Z, Ma F. Zhang Y, et al. Among authors: ma f. Cancer Cell. 2025 Mar 10;43(3):446-463.e7. doi: 10.1016/j.ccell.2025.01.007. Epub 2025 Feb 6. Cancer Cell. 2025. PMID: 39919737 Free article.

2

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.

Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.

3

Sacituzumab govitecan in HR⁺HER2^- metastatic breast cancer: the randomized phase 3 EVER-132-002 trial.

Xu B, Wang S, Yan M, Sohn J, Li W, Tang J, Wang X, Wang Y, Im SA, Jiang D, Valdez T, Dasgupta A, Zhang Y, Yan Y, Komatsubara KM, Chung WP, Ma F, Dai MS. Xu B, et al. Among authors: ma f. Nat Med. 2024 Dec;30(12):3709-3716. doi: 10.1038/s41591-024-03269-z. Epub 2024 Oct 1. Nat Med. 2024. PMID: 39354196 Free PMC article. Clinical Trial.

4

The relationship between systemic inflammation index, systemic immune-inflammatory index, and inflammatory prognostic index and 90-day outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.

Ma F, Li L, Xu L, Wu J, Zhang A, Liao J, Chen J, Li Y, Li L, Chen Z, Li W, Zhu Q, Zhu Y, Wu M. Ma F, et al. J Neuroinflammation. 2023 Sep 30;20(1):220. doi: 10.1186/s12974-023-02890-y. J Neuroinflammation. 2023. PMID: 37777768 Free PMC article.

5

CRISPR/Cas-Based MicroRNA Biosensors.

Zhang Q, Zhang X, Zou X, Ma F, Zhang CY. Zhang Q, et al. Among authors: ma f. Chemistry. 2023 Mar 16;29(16):e202203412. doi: 10.1002/chem.202203412. Epub 2023 Feb 2. Chemistry. 2023. PMID: 36477884 Review.

6

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming.

Wang T, Sun F, Li C, Nan P, Song Y, Wan X, Mo H, Wang J, Zhou Y, Guo Y, Helali AE, Xu D, Zhan Q, Ma F, Qian H. Wang T, et al. Among authors: ma f. Adv Sci (Weinh). 2023 Sep;10(25):e2300756. doi: 10.1002/advs.202300756. Epub 2023 Jul 13. Adv Sci (Weinh). 2023. PMID: 37442756 Free PMC article.

7

Association of Unhealthy Lifestyle and Genetic Risk Factors With Mild Cognitive Impairment in Chinese Older Adults.

Duan H, Zhou D, Xu N, Yang T, Wu Q, Wang Z, Sun Y, Li Z, Li W, Ma F, Chen Y, Du Y, Zhang M, Yan J, Sun C, Wang G, Huang G. Duan H, et al. Among authors: ma f. JAMA Netw Open. 2023 Jul 3;6(7):e2324031. doi: 10.1001/jamanetworkopen.2023.24031. JAMA Netw Open. 2023. PMID: 37462970 Free PMC article.

8

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.

Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, Zhai JT, Qian HL, Ma F. Li YQ, et al. Among authors: ma f. Mil Med Res. 2023 Jul 25;10(1):34. doi: 10.1186/s40779-023-00470-y. Mil Med Res. 2023. PMID: 37491281 Free PMC article.

9

Unveiling distinctions between mesenchymal stromal cells and stem cells by single-cell transcriptomic analysis.

Yan K, Ma F, Song X, Wang H, Liu P, Zhang J, Jin X, Han P, Zuo X, Kang YJ. Yan K, et al. Among authors: ma f. Heliyon. 2025 Feb 8;11(4):e42311. doi: 10.1016/j.heliyon.2025.e42311. eCollection 2025 Feb 28. Heliyon. 2025. PMID: 40034318 Free PMC article.

10

Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.

Mo H, Yu Y, Sun X, Ge H, Yu L, Guan X, Zhai J, Zhu A, Wei Y, Wang J, Yan X, Qian H, Xu B, Ma F. Mo H, et al. Among authors: ma f. Nat Med. 2024 Sep;30(9):2528-2539. doi: 10.1038/s41591-024-03088-2. Epub 2024 Jul 5. Nat Med. 2024. PMID: 38969879 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,305 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,305 results

Results by year